Custom Lucite deal toy marking the acquisition of two royalty interest in sales of breast cancer drug Orserdu. (24AKL125)
Custom Lucite deal toy marking the acquisition of two royalty interest in sales of breast cancer drug Orserdu. (24AKL125)
Crystal commemorative celebrating FDA approval of Ogsiveo, a treatment for desmoid tumors. (24aZH051)
Custom crystal deal toy commemorating the acquisition of Aspekt Solutions. The radiology services company is based in Greenbelt, Maryland. (23ALJ200)
Logo-themed financial tombstone commemorating a private placement by enVVeno Medical. The medical device company specializes in tissue-based treatment for venous (vein-related) diseases. (23AKL446)
Crystal deal toy marking a debt facility provided for Ocular Therapeutix. The biopharpharmaceutical commpany specializes in the treatment of diseases of the eye, using bioresorbable hydrogel-based technology. (23AJH088)
Financial tombstone, featuring a hospital building replica in crystal, celebrating the successful placment of “green” bonds by the Insel Group. The hospital network is based in Switzerland. (23LNL167)
Crystal financial tombstone commemorating a follow-on offering of stock by Intelligent Bio Solutions. The New York-based life sciences company develops non-invasive monitoring and diagnostic tests. (23AKL447)
Crystal financial tombstone commemorating a public offering of common stock by Kiora Pharmaceuticals. The California-based biotech company concentrates on developing and commercializing treatments for rare retinal diseases. (23AJH059)
Crystal tombstone celebrating a favorable verdict in an antitrust action against Gilead Sciences. The claim had centered on an earlier patent settlement involving Gilead and Teva. (23AKL380)
